{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T12:49:34Z","timestamp":1783342174135,"version":"3.54.6"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,5,16]],"date-time":"2013-05-16T00:00:00Z","timestamp":1368662400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s11033-013-2511-9","type":"journal-article","created":{"date-parts":[[2013,5,15]],"date-time":"2013-05-15T13:27:42Z","timestamp":1368624462000},"page":"4275-4280","source":"Crossref","is-referenced-by-count":7,"title":["The 46359CT polymorphism of DNMT3B is associated with the risk of cervical cancer"],"prefix":"10.1007","volume":"40","author":[{"given":"Daniel","family":"Hern\u00e1ndez-Sotelo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rub\u00e9n","family":"Garc\u00eda-Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaneth","family":"Castro-Coronel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J.","family":"Maga\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Antonio","family":"Leyva-Vazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz del Carmen","family":"Alarc\u00f3n-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"L\u00f3pez-Bayghen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berenice","family":"Illades-Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,16]]},"reference":[{"key":"2511_CR1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A et al (2011) Global cancer statistics. CA Cancer J Clin 61:69\u201390","journal-title":"CA Cancer J Clin"},{"key":"2511_CR2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0020-7292(00)90001-8","volume":"70","author":"JL Benedet","year":"2000","unstructured":"Benedet JL, Bender H, Jones H 3rd, Ngan HY, Pecorelli S (2000) FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO committee on gynecologic oncology. Int J Gynaecol Obstet 70:209\u2013262","journal-title":"Int J Gynaecol Obstet"},{"key":"2511_CR3","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/path.1866","volume":"208","author":"PJ Snijders","year":"2006","unstructured":"Snijders PJ, Steenbergen RD, Heideman DA, Meijer CJ (2006) HPV-mediated cervical carcinogenesis: concepts and clinical implications. J Pathol 208:152\u2013164","journal-title":"J Pathol"},{"key":"2511_CR4","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc798","volume":"2","author":"H zur Hausen","year":"2002","unstructured":"zur Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2:342\u2013350","journal-title":"Nat Rev Cancer"},{"key":"2511_CR5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nrc700","volume":"2","author":"RW Tindle","year":"2002","unstructured":"Tindle RW (2002) Immune evasion in human papillomavirus-associated cervical cancer. Nat Rev Cancer 2:59\u201365","journal-title":"Nat Rev Cancer"},{"key":"2511_CR6","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ygyno.2004.09.065","volume":"96","author":"HC Lai","year":"2005","unstructured":"Lai HC et al (2005) Matrix metalloproteinase 1 gene polymorphism as a prognostic predictor of invasive cervical cancer. Gynecol Oncol 96:314\u2013319","journal-title":"Gynecol Oncol"},{"key":"2511_CR7","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejogrb.2003.10.021","volume":"114","author":"M Comar","year":"2004","unstructured":"Comar M, Molin GD, Guaschino S, Campello C (2004) p53 at codon 72 polymorphism, human papillomavirus infection and cervical lesions: a cross-sectional study from northeastern Italy. Eur J Obstet Gynecol Rep Biol 114:210\u2013214","journal-title":"Eur J Obstet Gynecol Rep Biol"},{"key":"2511_CR8","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ygyno.2003.11.025","volume":"92","author":"A Kirkpatrick","year":"2004","unstructured":"Kirkpatrick A et al (2004) TNFalpha polymorphism frequencies in HPV-associated cervical dysplasia. Gynecol Oncol 92:675\u2013679","journal-title":"Gynecol Oncol"},{"key":"2511_CR9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ijc.10800","volume":"103","author":"HC Lai","year":"2003","unstructured":"Lai HC et al (2003) Single nucleotide polymorphism at Fas promoter is associated with cervical carcinogenesis. Int J Cancer 103:221\u2013225","journal-title":"Int J Cancer"},{"key":"2511_CR10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/IGC.0b013e31820da58b","volume":"21","author":"Y Li","year":"2011","unstructured":"Li Y, Liu F, Tan S, Li S (2011) P21 Ser31Arg polymorphism and cervical cancer risk: a meta-analysis. Int J Gynecol Cancer 21:445\u2013451","journal-title":"Int J Gynecol Cancer"},{"key":"2511_CR11","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1048-891x.2004.014040.x","volume":"14","author":"JE Lee","year":"2004","unstructured":"Lee JE et al (2004) Gene-gene and gene-environmental interactions of p53, p21, and IRF-1 polymorphisms in Korean women with cervix cancer. Int J Gynecol Cancer 14:118\u2013125","journal-title":"Int J Gynecol Cancer"},{"key":"2511_CR12","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1101\/gad.2037511","volume":"25","author":"AM Deaton","year":"2011","unstructured":"Deaton AM, Bird A (2011) CpG islands and the regulation of transcription. Genes Dev 25:1010\u20131022","journal-title":"Genes Dev"},{"key":"2511_CR13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.biocel.2008.09.006","volume":"41","author":"A Dobrovic","year":"2009","unstructured":"Dobrovic A, Kristensen LS (2009) DNA methylation, epimutations and cancer predisposition. Int J Biochem Cell Biol 41:34\u201339","journal-title":"Int J Biochem Cell Biol"},{"key":"2511_CR14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/carcin\/bgp220","volume":"31","author":"S Sharma","year":"2010","unstructured":"Sharma S, Kelly TK, Jones PA (2010) Epigenetics in cancer. Carcinogenesis 31:27\u201336","journal-title":"Carcinogenesis"},{"key":"2511_CR15","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1101\/gad.1594007","volume":"21","author":"HG Linhart","year":"2007","unstructured":"Linhart HG et al (2007) Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing. Genes Dev 21:3110\u20133122","journal-title":"Genes Dev"},{"key":"2511_CR16","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1093\/carcin\/bgm206","volume":"28","author":"Y Kanai","year":"2007","unstructured":"Kanai Y, Hirohashi S (2007) Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state. Carcinogenesis 28:2434\u20132442","journal-title":"Carcinogenesis"},{"key":"2511_CR17","first-page":"65","volume":"20","author":"BK Oh","year":"2007","unstructured":"Oh BK et al (2007) DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation. Int J Mol Med 20:65\u201373","journal-title":"Int J Mol Med"},{"key":"2511_CR18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1476-4598-7-15","volume":"7","author":"JD Roll","year":"2008","unstructured":"Roll JD, Rivenbark AG, Jones WD, Coleman WB (2008) DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines. Mol Cancer 7:15","journal-title":"Mol Cancer"},{"key":"2511_CR19","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.meegid.2009.05.012","volume":"9","author":"S Ezzikouri","year":"2009","unstructured":"Ezzikouri S et al (2009) Single nucleotide polymorphism in DNMT3B promoter and its association with hepatocellular carcinoma in a Moroccan population. Infect Genet Evol 9:877\u2013881","journal-title":"Infect Genet Evol"},{"key":"2511_CR20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1756-9966-27-24","volume":"27","author":"H Fan","year":"2008","unstructured":"Fan H, Zhang F, Hu J, Liu D, Zhao Z (2008) Promoter polymorphisms of DNMT3B and the risk of colorectal cancer in Chinese: a case-control study. J Exp Clin Cancer Res 27:24","journal-title":"J Exp Clin Cancer Res"},{"key":"2511_CR21","doi-asserted-by":"crossref","unstructured":"Hu J, Fan H, Liu D, Zhang F, Xu H (2010) DNMT3B promoter polymorphism and risk of gastric cancer. Dig Dis Sci 55:1011\u20131016","DOI":"10.1007\/s10620-009-0831-3"},{"key":"2511_CR22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ijc.24324","volume":"125","author":"B Iacopetta","year":"2009","unstructured":"Iacopetta B et al (2009) The MTHFR C677T and DeltaDNMT3B C-149T polymorphisms confer different risks for right- and left-sided colorectal cancer. Int J Cancer 125:84\u201390","journal-title":"Int J Cancer"},{"key":"2511_CR23","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1158\/1055-9965.EPI-05-0644","volume":"15","author":"JS Jones","year":"2006","unstructured":"Jones JS et al (2006) DNMT3b polymorphism and hereditary nonpolyposis colorectal cancer age of onset. Cancer Epidemiol Biomark Prev 15:886\u2013891","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"2511_CR24","first-page":"403","volume":"26","author":"SJ Lee","year":"2005","unstructured":"Lee SJ et al (2005) DNMT3B polymorphisms and risk of primary lung cancer. Carcinogenesis 26:403\u2013409","journal-title":"Carcinogenesis"},{"key":"2511_CR25","doi-asserted-by":"crossref","first-page":"R390","DOI":"10.1186\/bcr807","volume":"6","author":"KG Montgomery","year":"2004","unstructured":"Montgomery KG, Liu MC, Eccles DM, Campbell IG (2004) The DNMT3B C\u00a0\u2192\u00a0T promoter polymorphism and risk of breast cancer in a British population: a case-control study. Breast Cancer Res 6:R390\u2013394","journal-title":"Breast Cancer Res"},{"key":"2511_CR26","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","volume":"287","author":"D Solomon","year":"2002","unstructured":"Solomon D et al (2002) The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 287:2114\u20132119","journal-title":"JAMA"},{"key":"2511_CR27","unstructured":"Davis LG, Kuehl WM, Battey JF (1994) Basic methods in molecular biology. Appleton & Lange, Norwalk, Conn., 2nd ed. pp xiv, p. 777"},{"key":"2511_CR28","first-page":"2","volume-title":"Diagnostic molecular pathology: a practical approach","author":"CS Herrington","year":"1992","unstructured":"Herrington CS, McGee JOD (1992) Diagnostic molecular pathology: a practical approach. IRL Press at Oxford University Press, Oxford, p 2"},{"key":"2511_CR29","first-page":"641","volume-title":"Diagnostic molecular microbiology : principles and applications","author":"DH Persing","year":"1993","unstructured":"Persing DH (1993) Diagnostic molecular microbiology : principles and applications. Washington, American Society for Microbiology, p 641"},{"key":"2511_CR30","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/jmv.1890450321","volume":"45","author":"JL Vossler","year":"1995","unstructured":"Vossler JL, Forbes BA, Adelson MD (1995) Evaluation of the polymerase chain reaction for the detection of human papillomavirus from urine. J Med Virol 45:354\u2013360","journal-title":"J Med Virol"},{"key":"2511_CR31","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/infdis\/170.5.1077","volume":"170","author":"HU Bernard","year":"1994","unstructured":"Bernard HU et al (1994) Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 170:1077\u20131085","journal-title":"J Infect Dis"},{"key":"2511_CR32","first-page":"4992","volume":"62","author":"H Shen","year":"2002","unstructured":"Shen H et al (2002) A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer. Cancer Res 62:4992\u20134995","journal-title":"Cancer Res"},{"key":"2511_CR33","doi-asserted-by":"crossref","first-page":"28176","DOI":"10.1074\/jbc.M204734200","volume":"277","author":"N Beaulieu","year":"2002","unstructured":"Beaulieu N et al (2002) An essential role for DNA methyltransferase DNMT3B in cancer cell survival. J Biol Chem 277:28176\u201328181","journal-title":"J Biol Chem"},{"key":"2511_CR34","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/gut.2010.223602","volume":"60","author":"AE Ibrahim","year":"2011","unstructured":"Ibrahim AE et al (2011) Sequential DNA methylation changes are associated with DNMT3B overexpression in colorectal neoplastic progression. Gut 60:499\u2013508","journal-title":"Gut"},{"key":"2511_CR35","first-page":"860","volume":"40","author":"MW Luczak","year":"2012","unstructured":"Luczak MW et al (2012) Transcriptional analysis of CXCR4, DNMT3A, DNMT3B and DNMT1 gene expression in primary advanced uterine cervical carcinoma. Int J Oncol 40:860\u2013866","journal-title":"Int J Oncol"},{"key":"2511_CR36","doi-asserted-by":"crossref","unstructured":"Xiao Y, Word B, Hammons G, Lyn-Cook B (2011) Transcriptional activity of DNMT3B in pancreatic cancer cells: effects of \u2212149 (C\u00a0\u2192\u00a0T) promoter polymorphism. Biochem Biophys Res Commun 415:220\u2013223","DOI":"10.1016\/j.bbrc.2011.07.115"},{"key":"2511_CR37","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00384-011-1199-3","volume":"26","author":"Q Bao","year":"2011","unstructured":"Bao Q et al (2011) Genetic variation in the promoter of DNMT3B is associated with the risk of colorectal cancer. Int J Colorectal Dis 26:1107\u20131112","journal-title":"Int J Colorectal Dis"},{"key":"2511_CR38","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.oraloncology.2006.04.006","volume":"43","author":"KP Chang","year":"2007","unstructured":"Chang KP et al (2007) Promoter polymorphisms of DNMT3B and the risk of head and neck squamous cell carcinoma in Taiwan: a case-control study. Oral Oncol 43:345\u2013351","journal-title":"Oral Oncol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-013-2511-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-013-2511-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-013-2511-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T03:16:12Z","timestamp":1559358972000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-013-2511-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,16]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["2511"],"URL":"https:\/\/doi.org\/10.1007\/s11033-013-2511-9","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,16]]}}}